Skip to main content

Table 3 Univariate analysis of normalized KOOS for 13 patients suffering from KOA treated with BM-MSCs

From: Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study

Normalized KOOS sections

Baseline (mean)

6th month follow-up (mean)

P value

1 year follow-up (mean)

P value

2 years follow-up (mean)

P value

Symptoms

67.300

91.2308

0.000

89.9

0.000

88.7

0.000

Pain

62.585

89.0538

0.000

89.7

0.000

89.4

0.000

Daily life activity

64.223

90.8308

0.000

92.2

0.000

93

0.000

Sport

40.25

79.9769

0.000

81.1

0.000

81.6

0.000

Quality of life

34.162

75.4923

0.000

76.9

0.000

77.4

0.000